Evid Invest
Who owns CGEMWhat CGEM owns — n/a

Who owns Cullinan Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of CGEM from SEC Form 13F filings across 182 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 182 institutions disclosed 70.1M shares of Cullinan Therapeutics, Inc. worth $1.08B — about 114% of shares outstanding; the largest disclosed holder is MPM BIOIMPACT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

182

13F holders

$1.08B

value, 2026 filers

114%

of shares outstanding (70.1M sh)

23

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CGEM's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1MPM BIOIMPACT LLC9.7M$149.2M11.1%15.8%-0.1%
2Lynx1 Capital Management LP9.0M$137.6M21.3%14.6%0.0%
3BVF INC/IL5.8M$88.3M2.9%9.4%0.0%
4BlackRock, Inc.5.3M$81.7M0.0%8.7%+1.7%
5PRICE T ROWE ASSOCIATES INC /MD/4.1M$62.8M0.0%6.7%+6.9%
6Kynam Capital Management, LP3.1M$47.8M2.6%5.1%0.0%
7VANGUARD CAPITAL MANAGEMENT LLC2.6M$40.5M0.0%4.3%+1.1%
8STATE STREET CORP2.6M$40.0M0.0%4.2%-29.0%
9RTW INVESTMENTS, LP2.4M$36.3M0.4%3.8%0.0%
10Siren, L.L.C.1.8M$27.5M0.7%2.9%-5.3%
11GEODE CAPITAL MANAGEMENT, LLC1.4M$22.2M0.0%2.4%-6.4%
12Blue Owl Capital Holdings LP1.4M$21.5M3.9%2.3%-9.1%
13Venrock Adviser, LLC1.4M$21.2M1.0%2.2%0.0%
14DIMENSIONAL FUND ADVISORS LP1.1M$16.7M0.0%1.8%+3.6%
15GOLDMAN SACHS GROUP INC988,963$15.2M0.0%1.6%-1.3%
16Elmind Capital, LP962,792$14.8M3.7%1.6%+39.5%
17BOOTHBAY FUND MANAGEMENT, LLC953,126$14.6M0.2%1.5%-12.0%
18Affinity Asset Advisors, LLC875,760$13.4M0.5%1.4%0.0%
19Fisher Asset Management, LLC800,961$12.3M0.0%1.3%+2125.0%
20BOONE CAPITAL MANAGEMENT LLC690,814$10.6M2.8%1.1%-1.9%
21MORGAN STANLEY644,639$9.9M0.0%1%+2.5%
22VANGUARD PORTFOLIO MANAGEMENT LLC643,491$9.9M0.0%1%-12.9%
23TWIN FOCUS CAPITAL PARTNERS, LLC595,489$9.1M0.9%1%0.0%
24NORTHERN TRUST CORP558,159$8.6M0.0%0.9%-2.3%
25CHARLES SCHWAB INVESTMENT MANAGEMENT INC506,077$7.8M0.0%0.8%+9.1%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.